Actively Recruiting
Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation
Led by University of Illinois at Chicago · Updated on 2024-11-29
96
Participants Needed
1
Research Sites
498 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to examine the effects of different sedation drugs used for the awake fiberoptic intubation procedure. Benzodiazapines and narcotics (such as midazolam and fentanyl) are standard drugs used for sedation during awake fiberoptic intubation. Dexmedetomidine, midazolam, and fentanyl are approved by the Food and Drug Administration (FDA) procedural sedation. These drugs might be given to the patient regardless of their participation in the study. In addition to midazolam and fentanyl study subjects will also receive either dexmedetomidine or a placebo (a salt solution that contains no drug). It is believed that dexmedetomidine will not slow down breathing as much as the combination of the valium-like drug and narcotic. In our study, we are trying to determine if this is the best drug for sedation during an awake fiberoptic procedure.
CONDITIONS
Official Title
Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects with potentially difficult airways who require awake fiberoptic intubations will be identified from the OR schedule and the pre-operative clinic workups.
You will not qualify if you...
- Anyone who does not meet the inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Illinois
Chicago, Illinois, United States, 60612
Actively Recruiting
Research Team
A
Alexandra Barabanova, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here